English | Español
Patient Daily | Jul 7, 2026

15 and FARE announce back-to-school event for Kansas City food allergy families
Patient Daily | Jul 7, 2026

Study identifies conditions to improve stability of mRNA vaccine patches
Patient Daily | Jul 7, 2026

Telepractice resilience program may aid children who stutter, study finds
Patient Daily | Jul 7, 2026

Researchers at UT Arlington launch study on health effects of hookah smoking methods
Patient Daily | Jul 7, 2026

Review examines why antidepressants often fail in Alzheimer’s and Parkinson’s depression
Patient Daily | Jul 7, 2026

New review highlights potential of TCM polysaccharide hydrogels for wound healing
Patient Daily | Jul 7, 2026

Researchers report antibody-drug conjugate eradicates residual leukemia in clinical trial
Patient Daily | Jul 7, 2026

Compass Pathways reports durable results for psilocybin depression drug in late-stage trial

Trending
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Regulatory
M. R. Armstrong | Aug 4, 2026

Public Policy Solutions on 340B: 'The program has enriched big hospital execs'
+ Regulatory
G. N. Ball | Aug 5, 2026

Citizens Against Government Waste on 340B: 'Covered hospitals now generate millions of dollars of profit'